 Rebecca McCullough
Concepts (248)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Diseases, Alcoholic | 16 | 2022 | 93 | 4.090 |
Why?
| | Ethanol | 23 | 2025 | 608 | 4.020 |
Why?
| | Chemical and Drug Induced Liver Injury | 2 | 2024 | 137 | 1.540 |
Why?
| | Hepatocytes | 6 | 2022 | 220 | 1.320 |
Why?
| | Liver | 16 | 2025 | 1943 | 1.320 |
Why?
| | Receptor, Anaphylatoxin C5a | 2 | 2018 | 30 | 1.090 |
Why?
| | Carbon Tetrachloride | 2 | 2025 | 13 | 0.980 |
Why?
| | Wnt-5a Protein | 1 | 2024 | 23 | 0.920 |
Why?
| | Wnt3A Protein | 1 | 2024 | 10 | 0.920 |
Why?
| | Hepatic Stellate Cells | 1 | 2024 | 13 | 0.920 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2025 | 151 | 0.860 |
Why?
| | Binge Drinking | 1 | 2023 | 43 | 0.830 |
Why?
| | Mice, Inbred C57BL | 20 | 2025 | 5757 | 0.810 |
Why?
| | Inflammation | 9 | 2025 | 2837 | 0.790 |
Why?
| | Aldehydes | 6 | 2014 | 145 | 0.770 |
Why?
| | Alcoholism | 4 | 2024 | 807 | 0.760 |
Why?
| | Neurodegenerative Diseases | 1 | 2023 | 135 | 0.740 |
Why?
| | NF-kappa B | 1 | 2025 | 691 | 0.700 |
Why?
| | Fatty Acids | 3 | 2022 | 443 | 0.690 |
Why?
| | Mice | 27 | 2025 | 17787 | 0.640 |
Why?
| | Nanoparticles | 1 | 2025 | 481 | 0.620 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 383 | 0.590 |
Why?
| | Aging | 3 | 2025 | 1864 | 0.580 |
Why?
| | PTEN Phosphohydrolase | 4 | 2016 | 167 | 0.560 |
Why?
| | Protein Carbonylation | 5 | 2016 | 54 | 0.520 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2018 | 220 | 0.510 |
Why?
| | Animals | 32 | 2025 | 36940 | 0.500 |
Why?
| | MAP Kinase Kinase Kinases | 1 | 2016 | 73 | 0.490 |
Why?
| | Alcohol Drinking | 4 | 2025 | 828 | 0.460 |
Why?
| | Myeloid Cells | 1 | 2016 | 148 | 0.460 |
Why?
| | Adipose Tissue | 1 | 2018 | 635 | 0.430 |
Why?
| | Fatty Acid-Binding Proteins | 3 | 2013 | 70 | 0.360 |
Why?
| | Hepatitis, Alcoholic | 2 | 2021 | 13 | 0.360 |
Why?
| | Fatty Liver | 3 | 2014 | 243 | 0.350 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2016 | 437 | 0.350 |
Why?
| | Fatty Liver, Alcoholic | 2 | 2016 | 15 | 0.340 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2014 | 197 | 0.280 |
Why?
| | Lipid Peroxidation | 3 | 2014 | 153 | 0.270 |
Why?
| | Disease Models, Animal | 8 | 2025 | 4295 | 0.260 |
Why?
| | Diet, High-Fat | 3 | 2020 | 247 | 0.250 |
Why?
| | Public Opinion | 2 | 2023 | 65 | 0.240 |
Why?
| | Liver Cirrhosis | 2 | 2025 | 316 | 0.240 |
Why?
| | Proteins | 2 | 2012 | 1009 | 0.240 |
Why?
| | Gastrointestinal Microbiome | 2 | 2025 | 697 | 0.230 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2020 | 279 | 0.230 |
Why?
| | Immunologic Surveillance | 1 | 2025 | 25 | 0.230 |
Why?
| | Mice, Knockout | 5 | 2021 | 3015 | 0.230 |
Why?
| | Cell Transdifferentiation | 1 | 2024 | 31 | 0.230 |
Why?
| | Liver Regeneration | 1 | 2024 | 46 | 0.230 |
Why?
| | Apoptosis | 4 | 2018 | 2553 | 0.220 |
Why?
| | Immunity | 1 | 2025 | 143 | 0.220 |
Why?
| | Lactoylglutathione Lyase | 1 | 2024 | 18 | 0.220 |
Why?
| | Inflammasomes | 1 | 2025 | 131 | 0.210 |
Why?
| | Ethyl Ethers | 1 | 2022 | 4 | 0.200 |
Why?
| | Transendothelial and Transepithelial Migration | 1 | 2023 | 31 | 0.200 |
Why?
| | Wnt Signaling Pathway | 1 | 2024 | 192 | 0.200 |
Why?
| | Microglia | 1 | 2025 | 251 | 0.200 |
Why?
| | beta Catenin | 1 | 2024 | 253 | 0.190 |
Why?
| | Immune Tolerance | 1 | 2025 | 363 | 0.190 |
Why?
| | Glycoproteins | 2 | 2021 | 342 | 0.190 |
Why?
| | Central Nervous System Depressants | 2 | 2018 | 85 | 0.190 |
Why?
| | Complement Factor D | 2 | 2020 | 30 | 0.190 |
Why?
| | Proteomics | 4 | 2021 | 1111 | 0.180 |
Why?
| | Cytokines | 3 | 2018 | 2085 | 0.180 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2025 | 362 | 0.180 |
Why?
| | Oxidative Stress | 6 | 2016 | 1317 | 0.180 |
Why?
| | Fluorocarbons | 1 | 2023 | 117 | 0.170 |
Why?
| | Protein Phosphatase 2 | 1 | 2021 | 41 | 0.170 |
Why?
| | Mitochondria, Liver | 1 | 2011 | 73 | 0.170 |
Why?
| | Endoplasmic Reticulum | 2 | 2014 | 265 | 0.170 |
Why?
| | Extracellular Matrix | 1 | 2024 | 528 | 0.170 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2021 | 125 | 0.170 |
Why?
| | Multigene Family | 1 | 2011 | 198 | 0.170 |
Why?
| | Sirtuin 3 | 1 | 2011 | 61 | 0.170 |
Why?
| | Lipoproteins, LDL | 1 | 2020 | 116 | 0.160 |
Why?
| | Female | 12 | 2025 | 73304 | 0.160 |
Why?
| | Lymphatic Vessels | 1 | 2020 | 64 | 0.160 |
Why?
| | Sarcopenia | 1 | 2021 | 83 | 0.160 |
Why?
| | Kupffer Cells | 2 | 2017 | 50 | 0.160 |
Why?
| | Hippocampus | 1 | 2025 | 895 | 0.160 |
Why?
| | Intestinal Mucosa | 2 | 2025 | 623 | 0.160 |
Why?
| | Endothelial Cells | 1 | 2025 | 785 | 0.160 |
Why?
| | Premature Birth | 1 | 2023 | 333 | 0.150 |
Why?
| | Sulfhydryl Compounds | 1 | 2011 | 189 | 0.150 |
Why?
| | Tandem Mass Spectrometry | 4 | 2021 | 532 | 0.150 |
Why?
| | Anaphylatoxins | 1 | 2018 | 7 | 0.150 |
Why?
| | Models, Molecular | 4 | 2014 | 1570 | 0.150 |
Why?
| | Blotting, Western | 2 | 2016 | 1226 | 0.150 |
Why?
| | Liver Neoplasms | 1 | 2025 | 786 | 0.150 |
Why?
| | Histones | 1 | 2024 | 636 | 0.150 |
Why?
| | Adipokines | 1 | 2018 | 49 | 0.150 |
Why?
| | Gastrointestinal Tract | 1 | 2020 | 195 | 0.140 |
Why?
| | Primary Cell Culture | 1 | 2018 | 171 | 0.140 |
Why?
| | Protective Agents | 1 | 2018 | 41 | 0.140 |
Why?
| | Male | 19 | 2025 | 67762 | 0.140 |
Why?
| | Rats | 4 | 2017 | 5647 | 0.130 |
Why?
| | Humans | 23 | 2025 | 137585 | 0.130 |
Why?
| | Complement Pathway, Alternative | 1 | 2018 | 122 | 0.130 |
Why?
| | Evolution, Molecular | 1 | 2011 | 493 | 0.130 |
Why?
| | Phosphorylation | 2 | 2016 | 1759 | 0.130 |
Why?
| | Adipocytes | 1 | 2018 | 222 | 0.130 |
Why?
| | Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2016 | 14 | 0.130 |
Why?
| | MAP Kinase Kinase 4 | 1 | 2016 | 29 | 0.130 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2023 | 605 | 0.130 |
Why?
| | Immune System | 1 | 2018 | 177 | 0.130 |
Why?
| | Chemical and Drug Induced Liver Injury, Chronic | 1 | 2016 | 12 | 0.130 |
Why?
| | Extracellular Vesicles | 1 | 2018 | 146 | 0.130 |
Why?
| | Complement C1q | 1 | 2016 | 37 | 0.120 |
Why?
| | Immunohistochemistry | 2 | 2016 | 1738 | 0.120 |
Why?
| | Toll-Like Receptor 4 | 1 | 2017 | 273 | 0.120 |
Why?
| | Amino Acid Sequence | 4 | 2014 | 2139 | 0.120 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2016 | 346 | 0.120 |
Why?
| | Rats, Wistar | 1 | 2016 | 455 | 0.110 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2017 | 455 | 0.110 |
Why?
| | Immunoglobulin M | 1 | 2016 | 289 | 0.110 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2014 | 110 | 0.100 |
Why?
| | Heat-Shock Proteins | 1 | 2014 | 143 | 0.100 |
Why?
| | Adenosine Triphosphatases | 1 | 2014 | 168 | 0.100 |
Why?
| | Complement Activation | 1 | 2016 | 415 | 0.100 |
Why?
| | Lipopolysaccharides | 1 | 2016 | 886 | 0.100 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2014 | 130 | 0.090 |
Why?
| | Molecular Sequence Data | 3 | 2011 | 2900 | 0.090 |
Why?
| | Aortic Valve Stenosis | 1 | 2014 | 229 | 0.090 |
Why?
| | Dietary Fats | 1 | 2013 | 304 | 0.090 |
Why?
| | MicroRNAs | 1 | 2017 | 692 | 0.090 |
Why?
| | Enzyme Activation | 2 | 2013 | 810 | 0.080 |
Why?
| | Gene Expression Regulation | 3 | 2017 | 2607 | 0.080 |
Why?
| | Chromatography, Liquid | 2 | 2013 | 433 | 0.080 |
Why?
| | Protein Conformation | 1 | 2012 | 934 | 0.080 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 2 | 2012 | 114 | 0.070 |
Why?
| | Immunoprecipitation | 2 | 2021 | 155 | 0.070 |
Why?
| | Homeostasis | 2 | 2021 | 621 | 0.070 |
Why?
| | DNA Primers | 2 | 2012 | 515 | 0.060 |
Why?
| | Protein Structure, Tertiary | 2 | 2014 | 861 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 2 | 2011 | 2486 | 0.060 |
Why?
| | Biomarkers | 3 | 2021 | 4149 | 0.060 |
Why?
| | Diethylnitrosamine | 1 | 2025 | 5 | 0.060 |
Why?
| | Signal Transduction | 4 | 2017 | 5079 | 0.060 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 2014 | 49 | 0.050 |
Why?
| | Cells, Cultured | 2 | 2023 | 4193 | 0.050 |
Why?
| | Hep G2 Cells | 1 | 2014 | 67 | 0.050 |
Why?
| | Alanine Transaminase | 2 | 2016 | 157 | 0.050 |
Why?
| | Hawaii | 1 | 2023 | 34 | 0.050 |
Why?
| | Macrophages | 2 | 2024 | 1547 | 0.050 |
Why?
| | Dehydroepiandrosterone | 1 | 2023 | 51 | 0.050 |
Why?
| | Models, Chemical | 1 | 2014 | 263 | 0.050 |
Why?
| | Thiobarbituric Acid Reactive Substances | 1 | 2012 | 30 | 0.050 |
Why?
| | Malondialdehyde | 1 | 2012 | 29 | 0.050 |
Why?
| | Heme | 1 | 2023 | 78 | 0.050 |
Why?
| | Acrolein | 1 | 2012 | 23 | 0.050 |
Why?
| | Cytochrome P-450 CYP3A | 1 | 2023 | 88 | 0.050 |
Why?
| | Lactic Acid | 1 | 2024 | 305 | 0.050 |
Why?
| | Triglycerides | 2 | 2016 | 524 | 0.050 |
Why?
| | Tretinoin | 1 | 2023 | 123 | 0.050 |
Why?
| | Glycolysis | 1 | 2024 | 321 | 0.050 |
Why?
| | Eye Proteins | 1 | 2021 | 92 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2013 | 597 | 0.040 |
Why?
| | Complement C2 | 1 | 2020 | 7 | 0.040 |
Why?
| | Microsomes, Liver | 1 | 2011 | 86 | 0.040 |
Why?
| | Complement C4 | 1 | 2020 | 28 | 0.040 |
Why?
| | Complement C5 | 1 | 2020 | 81 | 0.040 |
Why?
| | Lymphocyte Activation | 1 | 2025 | 1142 | 0.040 |
Why?
| | Glycosylation | 1 | 2011 | 151 | 0.040 |
Why?
| | Intercellular Junctions | 1 | 2020 | 40 | 0.040 |
Why?
| | NAD | 1 | 2011 | 77 | 0.040 |
Why?
| | Myoblasts | 1 | 2021 | 84 | 0.040 |
Why?
| | Proteostasis | 1 | 2020 | 29 | 0.040 |
Why?
| | Sequence Alignment | 1 | 2011 | 343 | 0.040 |
Why?
| | Iron | 1 | 2023 | 313 | 0.040 |
Why?
| | Acetylation | 1 | 2011 | 248 | 0.040 |
Why?
| | Permeability | 1 | 2020 | 161 | 0.040 |
Why?
| | Boston | 1 | 2020 | 91 | 0.040 |
Why?
| | Pregnancy | 2 | 2023 | 6763 | 0.040 |
Why?
| | Complement Factor B | 1 | 2020 | 109 | 0.040 |
Why?
| | Microscopy, Confocal | 1 | 2011 | 325 | 0.040 |
Why?
| | Organ Specificity | 1 | 2020 | 305 | 0.040 |
Why?
| | Chromatin | 1 | 2024 | 519 | 0.040 |
Why?
| | Species Specificity | 1 | 2011 | 585 | 0.040 |
Why?
| | Complement C3 | 1 | 2020 | 209 | 0.040 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2011 | 177 | 0.040 |
Why?
| | Birth Weight | 1 | 2023 | 516 | 0.040 |
Why?
| | Water | 1 | 2023 | 460 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2021 | 500 | 0.040 |
Why?
| | Drosophila melanogaster | 1 | 2011 | 233 | 0.040 |
Why?
| | Congresses as Topic | 1 | 2020 | 233 | 0.040 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2025 | 900 | 0.040 |
Why?
| | Genome, Human | 1 | 2011 | 425 | 0.040 |
Why?
| | Cell Movement | 1 | 2023 | 967 | 0.040 |
Why?
| | Tumor Suppressor Proteins | 1 | 2020 | 327 | 0.040 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 1062 | 0.040 |
Why?
| | Recombinant Proteins | 1 | 2011 | 1353 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 313 | 0.030 |
Why?
| | Caenorhabditis elegans | 1 | 2011 | 306 | 0.030 |
Why?
| | Complement System Proteins | 1 | 2020 | 327 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2022 | 660 | 0.030 |
Why?
| | Base Sequence | 1 | 2011 | 2181 | 0.030 |
Why?
| | Protein Binding | 2 | 2014 | 2224 | 0.030 |
Why?
| | Homeodomain Proteins | 1 | 2020 | 506 | 0.030 |
Why?
| | Endothelium, Vascular | 1 | 2023 | 927 | 0.030 |
Why?
| | Complement C1 Inactivator Proteins | 1 | 2016 | 6 | 0.030 |
Why?
| | Complement C1 Inhibitor Protein | 1 | 2016 | 11 | 0.030 |
Why?
| | Lipogenesis | 1 | 2016 | 61 | 0.030 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 99 | 0.030 |
Why?
| | Random Allocation | 1 | 2016 | 353 | 0.030 |
Why?
| | Hyaluronic Acid | 1 | 2017 | 225 | 0.030 |
Why?
| | Solubility | 1 | 2016 | 245 | 0.030 |
Why?
| | Cell Death | 1 | 2016 | 374 | 0.030 |
Why?
| | Cytochrome P-450 CYP4A | 1 | 2014 | 4 | 0.030 |
Why?
| | CD36 Antigens | 1 | 2014 | 36 | 0.030 |
Why?
| | Glutathione | 1 | 2016 | 356 | 0.030 |
Why?
| | Unfolded Protein Response | 1 | 2014 | 59 | 0.030 |
Why?
| | Echocardiography, Transesophageal | 1 | 2014 | 96 | 0.030 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2013 | 33 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2013 | 24 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 3412 | 0.030 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 1 | 2013 | 57 | 0.030 |
Why?
| | Age Factors | 1 | 2020 | 3295 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2020 | 3556 | 0.020 |
Why?
| | Protein Folding | 1 | 2014 | 280 | 0.020 |
Why?
| | Anilino Naphthalenesulfonates | 1 | 2012 | 10 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2017 | 1242 | 0.020 |
Why?
| | Coronary Artery Bypass | 1 | 2014 | 234 | 0.020 |
Why?
| | Ubiquitination | 1 | 2012 | 102 | 0.020 |
Why?
| | Prognosis | 1 | 2020 | 4030 | 0.020 |
Why?
| | Organ Size | 1 | 2013 | 477 | 0.020 |
Why?
| | Immunity, Innate | 1 | 2018 | 828 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 2012 | 534 | 0.020 |
Why?
| | Adiponectin | 1 | 2013 | 244 | 0.020 |
Why?
| | Cholesterol | 1 | 2013 | 410 | 0.020 |
Why?
| | Patient Selection | 1 | 2014 | 696 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 976 | 0.020 |
Why?
| | Computer Simulation | 1 | 2014 | 978 | 0.020 |
Why?
| | Hospital Mortality | 1 | 2014 | 911 | 0.020 |
Why?
| | Survival Rate | 1 | 2014 | 1972 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2012 | 739 | 0.020 |
Why?
| | Lipids | 1 | 2013 | 672 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2013 | 712 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2167 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2013 | 2833 | 0.010 |
Why?
| | Transcription Factors | 1 | 2013 | 1719 | 0.010 |
Why?
| | Risk Assessment | 1 | 2014 | 3457 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2013 | 2426 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2014 | 2654 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2014 | 7635 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2014 | 10811 | 0.010 |
Why?
| | Middle Aged | 1 | 2020 | 33479 | 0.010 |
Why?
| | Adult | 1 | 2020 | 37929 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2014 | 15657 | 0.010 |
Why?
|
|
McCullough's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|